SO WHAT: If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is ...

NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Contra Costa County Fire Protection District officials said last week they are taking steps to protect drivers and ...

The Sudanese government has suspended its participation in the global hunger-monitoring system on the eve of a report that’s expected to show famine spreading across the country, a step likely ...

The new lawsuit completely restructures the case that Tyre Nichols' family will make against the city, even as the core ...

Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a ...

Finally! This one took way longer then it should of. I suspect that the growth was delayed due to a fungus gnat infestation i ...

TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion ...

Lilly’s bid to acquire Scorpion was driven by the Scorpion’s PI3Kα inhibitor ... as per GlobalData’s State of the Biopharmaceutical Industry report. Oncology trials will outnumber CNS and ...

We maintain cautious stance on TransMedics investment due to high-risk factors. Read here for an analysis of TMDX stock drop and future prospects.

TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and the release of a short-seller report. Data demonstrates that the ...

TransMedics' stock price has dropped $9.84, or 13%, since Scorpion released a report, titled "Walk Like An Egyptian," leveling serious allegations against the company, including fraud, organ ...